UNSPSC 51373454: Codeine/phenylpropanolamine/promethazine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373454 Codeine/phenylpropanolamine/promethazine is a Commodity code that in practice captures state and local procurement of pharmaceutical products and drug-related public health supplies, including naloxone and safe drug deactivation systems for community health and emergency response use. The issuing bodies soliciting under this code span county health departments and state cooperative purchasing alliances. Seminole County, Florida and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represent recent buyers. Work under the code includes annual supply contracts for naloxone and drug deactivation equipment for public health delivery, and larger multi-source pharmaceutical supply agreements that bundle generic medications and over-the-counter products across multiple state and local facilities through authorized wholesalers.

Geographic activity centers on Florida and Minnesota, with MMCAP's RFP extending scope to participating states including Oregon. Recent opportunities include Seminole County's IFB60459723LAS, an Invitation for Bid posted June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 and quarterly deliveries to Sanford, Florida; and MMCAP's S1070000015802, a Request for Proposal posted January 20, 2026 with a response deadline of March 26, 2026 to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities. Vendor requirements in both solicitations include cGMP and DSCSA compliance, E-Verify authorization, comprehensive insurance coverage, and adherence to federal regulatory standards.